128 related articles for article (PubMed ID: 18382014)
1. Magnetic resonance whole body imaging at 3 Tesla: feasibility and findings in a cohort of asymptomatic medical doctors.
Lo GG; Ai V; Au-Yeung KM; Chan JK; Li KW; Chien D
Hong Kong Med J; 2008 Apr; 14(2):90-6. PubMed ID: 18382014
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study.
Hegenscheid K; Kühn JP; Völzke H; Biffar R; Hosten N; Puls R
Rofo; 2009 Aug; 181(8):748-59. PubMed ID: 19598074
[TBL] [Abstract][Full Text] [Related]
3. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
4. Whole-body magnetization transfer contrast imaging.
Boss A; Martirosian P; Küper K; Fierlbeck G; Claussen CD; Schick F
J Magn Reson Imaging; 2006 Nov; 24(5):1183-7. PubMed ID: 17031816
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
6. Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner.
Sadick M; Schock D; Kraenzlin B; Gretz N; Schoenberg SO; Michaely HJ
Invest Radiol; 2009 Aug; 44(8):469-75. PubMed ID: 19465861
[TBL] [Abstract][Full Text] [Related]
7. Ultrafast whole-body MR angiography with two-dimensional parallel imaging at 3.0 T: feasibility study.
Fenchel M; Doering J; Seeger A; Kramer U; Rittig K; Klumpp B; Claussen CD; Miller S
Radiology; 2009 Jan; 250(1):254-63. PubMed ID: 19001152
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of malignant tumor metabolism: whole-body image fusion of DWI/CT vs. PET/CT.
Reiner CS; Fischer MA; Hany T; Stolzmann P; Nanz D; Donati OF; Weishaupt D; von Schulthess GK; Scheffel H
Acad Radiol; 2011 Aug; 18(8):940-6. PubMed ID: 21718953
[TBL] [Abstract][Full Text] [Related]
9. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
10. Impact of magnetic resonance imaging on preoperative planning for breast cancer surgery.
Law Y; Cheung PS; Lau S; Lo GG
Hong Kong Med J; 2013 Aug; 19(4):294-9. PubMed ID: 23832947
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging for lung cancer detection: experience in a population of more than 10,000 healthy individuals.
Wu NY; Cheng HC; Ko JS; Cheng YC; Lin PW; Lin WC; Chang CY; Liou DM
BMC Cancer; 2011 Jun; 11():242. PubMed ID: 21668954
[TBL] [Abstract][Full Text] [Related]
12. [Whole-body MRI in preoperative diagnostics of breast cancer--a comparison with [corrected] staging methods according to the S 3 guidelines].
Hausmann D; Kern C; Schröder MT; Sütterlin M; Schönberg SO; Neff KW; Dinter DJ
Rofo; 2011 Dec; 183(12):1130-7. PubMed ID: 22068844
[TBL] [Abstract][Full Text] [Related]
13. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
14. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-sensitized ophthalmic magnetic resonance imaging free of geometric distortion at 3.0 and 7.0 T: a feasibility study in healthy subjects and patients with intraocular masses.
Paul K; Graessl A; Rieger J; Lysiak D; Huelnhagen T; Winter L; Heidemann R; Lindner T; Hadlich S; Zimpfer A; Pohlmann A; Endemann B; Krüger PC; Langner S; Stachs O; Niendorf T
Invest Radiol; 2015 May; 50(5):309-21. PubMed ID: 25612144
[TBL] [Abstract][Full Text] [Related]
16. Cardiac cine imaging at 3 Tesla: initial experience with a 32-element body-array coil.
Fenchel M; Deshpande VS; Nael K; Finn JP; Miller S; Ruehm S; Laub G
Invest Radiol; 2006 Aug; 41(8):601-8. PubMed ID: 16829742
[TBL] [Abstract][Full Text] [Related]
17. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
Li S; Sun F; Jin ZY; Xue HD; Li ML
J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
[TBL] [Abstract][Full Text] [Related]
18. Rapid whole-brain magnetic resonance imaging with isotropic resolution at 3 Tesla.
Edelman RR; Dunkle E; Koktzoglou I; Griffin A; Russell EJ; Ankenbrandt W; Ragin A; Carrillo A
Invest Radiol; 2009 Jan; 44(1):54-9. PubMed ID: 19060723
[TBL] [Abstract][Full Text] [Related]
19. Renal magnetic resonance angiography at 3.0 Tesla using a 32-element phased-array coil system and parallel imaging in 2 directions.
Fenchel M; Nael K; Deshpande VS; Finn JP; Kramer U; Miller S; Ruehm S; Laub G
Invest Radiol; 2006 Sep; 41(9):697-703. PubMed ID: 16896305
[TBL] [Abstract][Full Text] [Related]
20. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
